Log in to save to my catalogue

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83531e96aea54761b2882fb71c11eee2

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

About this item

Full title

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Publisher

Switzerland: MDPI AG

Journal title

Vaccines (Basel), 2024-10, Vol.12 (10), p.1148

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Introduction: The advent of lipid nanoparticles (LNPs) as a delivery platform for mRNA therapeutics has revolutionized the biomedical field, particularly in treating infectious diseases, cancer, genetic disorders, and metabolic diseases. Recent Advances in Therapeutic LNPs: LNPs, composed of ionizable lipids, phospholipids, cholesterol, and polyeth...

Alternative Titles

Full title

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_83531e96aea54761b2882fb71c11eee2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83531e96aea54761b2882fb71c11eee2

Other Identifiers

ISSN

2076-393X

E-ISSN

2076-393X

DOI

10.3390/vaccines12101148

How to access this item